Transitioning Neovascular Age Related Macular Degeneration Patients to Aflibercept Following an Initial Treat And Extend Dosing Regimen: 18 Month Results

被引：0
|
作者：
Homer, Natalie [1 ]
Grewal, Dilraj Singh [1 ]
Lyon, Alice T. [1 ]
Mirza, Rukhsana [1 ]
Gill, Manjot [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Ophthalmol, Chicago, IL 60611 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 552 imaging methods (CT; FA; ICG; MRI; OCT; RTA; SLO ultrasound); 453 choroid: neovascularization;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3975
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration
    Cabral, Diogo
    Coscas, Florence
    Pereira, Telmo
    Francais, Catherine
    Geraldes, Carlos
    Laiginhas, Rita
    Rodrigues, Catarina
    Kashi, Alexis Khorrami
    Nogueira, Vanda
    Falcao, Manuel
    Papoila, Ana Luisa
    Lupidi, Marco
    Coscas, Gabriel
    Cohen, Salomon Yves
    Souied, Eric
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (03):
  • [32] Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial
    Hatz, Katja B.
    Pruente, Christian
    Binningen, Vistaklinik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [33] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration
    Wada, Iori
    Oshima, Yuji
    Fukuda, Yosuke
    Shiose, Satomi
    Kano, Kumiko
    Ishikawa, Keijiro
    Nakao, Shintaro
    Kaizu, Yoshihiro
    Hasegawa, Eiichi
    Kannan, Ram
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    CLINICAL OPHTHALMOLOGY, 2025, 19 : 835 - 845
  • [35] Novel metrics for evaluating decision making in a 'Treat and Extend' regimen for neovascular age related macular degeneration
    McLeish, Bethan
    Morris, Anna
    Karpoor, Meena
    Babar, Tehmoor
    Narendran, Niro
    Yang, Yit
    EYE, 2022, 36 (10) : 1994 - 1999
  • [36] Novel metrics for evaluating decision making in a ‘Treat and Extend’ regimen for neovascular age related macular degeneration
    Bethan McLeish
    Anna Morris
    Meena Karpoor
    Tehmoor Babar
    Niro Narendran
    Yit Yang
    Eye, 2022, 36 : 1994 - 1999
  • [37] Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a "Treat-and-Extend" Regimen
    Traine, Peter G.
    Pfister, Isabel B.
    Zandi, Souska
    Spindler, Jan
    Garweg, Justus G.
    OPHTHALMOLOGY RETINA, 2019, 3 (05): : 393 - 399
  • [38] Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study
    Souied, Eric H.
    Holz, Frank G.
    Hykin, Philip G.
    Midena, Edoardo
    Wolf, Sebastian
    Allmeier, Helmut
    Mitchell, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [39] Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration
    Nanji, Keean
    Kennedy, Kevin
    Fung, Matthew
    Xie, Jim
    Hatamnejad, Amin
    Garg, Sunir J.
    Wykoff, Charles C.
    Chaudhary, Varun
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2025, 60 (01): : e92 - e99
  • [40] Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
    Ishibashi, Koki
    Haruta, Masatoshi
    Ishibashi, Yumi
    Noda, Rie
    Dake, Shotaro
    Yoshida, Shigeo
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
12345